shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > India News > Article > Bharat Biotech fixes price of Covaxin at Rs 600 for states Rs 1200 for pvt hospitals

Bharat Biotech fixes price of Covaxin at Rs 600 for states, Rs 1,200 for pvt hospitals

Updated on: 25 April,2021 08:32 AM IST  |  New Delhi
PTI |

In a statement, Bharat Biotech Chairman and Managing Director Krishna M Ella said the company is supplying the vaccine to the central government at Rs 150 per dosage and the government on its part is distributing it free of cost.

Bharat Biotech fixes price of Covaxin at Rs 600 for states, Rs 1,200 for pvt hospitals

A frontline worker gets a Covaxin shot at JJ Hospital in south Mumbai. File pic

Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage.


The Hyderabad-based vaccine major also said that it would provide the vaccine to private hospitals at Rs 1,200 per dosage.


In a statement, Bharat Biotech Chairman and Managing Director Krishna M Ella said the company is supplying the vaccine to the central government at Rs 150 per dosage and the government on its part is distributing it free of cost.


"We would like to state that more than 50 per cent of our capacities have been reserved for central government  supplies," Ella said.

Recovering the cost is essential in the journey of innovation towards other vaccines such as intranasal Covid-19, Chikungunya, Zika, Cholera and others, he added.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK